Firm aims to develop a way of tracing Covid-19 in wastewater

Integumen, which uses AI technology for testing cosmetics and skincare products, said the Covid-19 pandemic has given it a number of new business opportunities.
Gerard Brandon, CEO of IntegumenGerard Brandon, CEO of Integumen
Gerard Brandon, CEO of Integumen

The York-based firm said these include real-time water contamination detection and environment sector solutions, which resulted in agreements with Modern Water, Avacta Group and Aptamer Group for the development of detection services that provide immediate alerts to authorities to contain Covid-19 hotspots.

The firm said contamination detection in wastewater is becoming an increasingly important tool in the fight against the disease.

Hide Ad
Hide Ad

With much of the pharma industry delaying clinical trials, Integumen has launched the world's first remote clinical skin trials platform.

By harvesting the microbiome of a human volunteer's skin, transporting it to the Labskin laboratory to be transplanted onto laboratory-grown skin, the firm said it can create an exact replica of the human volunteer's skin microflora.

The platform allows trials to happen ethically and efficiently with all clinical and data storage protocols being followed and distantly controlled. Swabbing can be done under remote video/AI supervision in the human volunteer's home, enabling companies to restart their clinical programmes.

The group reported revenues of £1m in the six months to June 30. This was up from £347,000 in the equivalent period in 2019.

Hide Ad
Hide Ad

Gerard Brandon, CEO of Integumen, said: "Over the past two years, Integumen has transformed from a struggling health services business into a revenue-generating company focused on providing integrated environmental, skin and health specialties underpinned by scientific expertise and advanced by AI.

"As the business continues to grow and evolve through collaboration and acquisition, unaudited revenues were up 290 per cent for the first half of 2020. Third quarter sales are expected to be in excess of £1m and guidance remains at £4m for 2020."

Related topics:

Comment Guidelines

National World encourages reader discussion on our stories. User feedback, insights and back-and-forth exchanges add a rich layer of context to reporting. Please review our Community Guidelines before commenting.